[HTML][HTML] The diagnosis of exclusion: an ongoing uncertainty

HL Fred - Texas Heart Institute Journal, 2013 - ncbi.nlm.nih.gov
(CPC). The case itself taught me a lot, but it also stimulated me to teach myself even more.
What I learned prompts this editorial. Case Summary. A 27-year-old white woman presented …

Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 …

J Kang, JS Lee, SW Lee, JB Lee, YM Oh - Respiratory Research, 2021 - Springer
Background Which patients should receive dual therapy as initial treatment for chronic
obstructive pulmonary disease (COPD) is only loosely defined. We evaluated if a lower …

Cardiovascular Comorbidities of COPD: When Do they Occur and How are they Managed?

A Angelakas, C Vlachopoulos… - Current Respiratory …, 2013 - ingentaconnect.com
Chronic obstructive pulmonary disease (COPD) is highly prevalent worldwide. Its morbidity
and mortality are increasing and it is predicted to be the third leading cause of death by …

[PDF][PDF] Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV

J Kang, JS Lee, SW Lee, JB Lee, YM Oh - 2021 - respiratory-research.biomedcentral …
Background: Which patients should receive dual therapy as initial treatment for chronic
obstructive pulmonary dis‑ease (COPD) is only loosely defined. We evaluated if a lower …

[PDF][PDF] Οι φαινότυποι της χρόνιας αποφρακτικής πνευμονοπάθειας

Ε για την Προώθηση - academia.edu
Η χρόνια αποφρακτική πνευμονοπάθεια (ΧΑΠ) είναι φλεγμονώδης, ετερογενής πάθηση, με
παθολογοανατομικές και παθοφυσιολογικές αποκλίσεις, κλινικές παραλλαγές και …

The phenotypes of chronic obstructive pulmonary disease.

AG Mathioudakis… - Archives of Hellenic …, 2014 - search.ebscohost.com
Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory disease
with pathological and pathophysiological variations, clinical subtypes and extrapulmonary …